Resting Heart Rate and Long-term Outcomes Among the African American Population: Insights From the Jackson Heart Study
暂无分享,去创建一个
Lesley H. Curtis | Emily C. O'Brien | Robert J. Mentz | Chad Blackshear | L. Curtis | Adrian F. Hernandez | Melissa A. Greiner | E. O'Brien | C. Blackshear | A. DeVore | Takeki Suzuki | R. Mentz | Takeki Suzuki | Emily C. O’Brien | Kishan S. Parikh | Adam D. DeVore | Joseph F. Maher | K. Parikh | Joseph Maher
[1] C. Yancy,et al. Racial differences in heart failure therapeutics. , 2010, Heart failure clinics.
[2] A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. , 2001 .
[3] C. Yancy,et al. The prognostic significance of heart rate in patients hospitalized for heart failure with reduced ejection fraction in sinus rhythm: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study With Tolvaptan) trial. , 2013, JACC. Heart failure.
[4] Dongfeng Zhang,et al. Resting heart rate and all-cause and cardiovascular mortality in the general population: a meta-analysis , 2015, Canadian Medical Association Journal.
[5] R S Paffenbarger,et al. Heart rate and cardiovascular mortality: the Framingham Study. , 1987, American heart journal.
[6] D. Mozaffarian,et al. Heart disease and stroke statistics--2014 update: a report from the American Heart Association. , 2014, Circulation.
[7] D. Bluemke,et al. Resting heart rate as predictor for left ventricular dysfunction and heart failure: MESA (Multi-Ethnic Study of Atherosclerosis). , 2014, Journal of the American College of Cardiology.
[8] S. Solomon,et al. Prognostic importance of temporal changes in resting heart rate in heart failure patients: an analysis of the CHARM program. , 2015, European heart journal.
[9] Hassan Khan,et al. Resting Heart Rate and Risk of Incident Heart Failure: Three Prospective Cohort Studies and a Systematic Meta‐Analysis , 2015, Journal of the American Heart Association.
[10] N. Breslow,et al. Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. , 1987, IARC scientific publications.
[11] U. Heidland,et al. Left Ventricular Muscle Mass and Elevated Heart Rate Are Associated With Coronary Plaque Disruption , 2001, Circulation.
[12] Peter J. Schwartz,et al. Heart-rate profile during exercise as a predictor of sudden death. , 2005, The New England journal of medicine.
[13] J. Cohn,et al. Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group. , 1999, Journal of cardiac failure.
[14] G. Zou,et al. A modified poisson regression approach to prospective studies with binary data. , 2004, American journal of epidemiology.
[15] A. Folsom,et al. Long‐term association between self‐reported signs and symptoms and heart failure hospitalizations: the Atherosclerosis Risk In Communities (ARIC) Study , 2010, European journal of heart failure.
[16] S. Yusuf,et al. Resting heart rate is associated with renal disease outcomes in patients with vascular disease: results of the ONTARGET and TRANSCEND studies , 2015, Journal of internal medicine.
[17] Jean-Claude Tardif,et al. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. , 2005, European heart journal.
[18] Susan Cheng,et al. Long‐term Cardiovascular Risks Associated With an Elevated Heart Rate: The Framingham Heart Study , 2014, Journal of the American Heart Association.
[19] P. Palatini. Heart rate as a cardiovascular risk factor: do women differ from men? , 2001, Annals of medicine.
[20] Jean-Claude Tardif,et al. Resting heart rate in cardiovascular disease. , 2007, Journal of the American College of Cardiology.
[21] M. Gold,et al. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial , 2011 .
[22] Michael Böhm,et al. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial , 2010, The Lancet.
[23] M. Andrew,et al. Recruiting African-American research participation in the Jackson Heart Study: methods, response rates, and sample description. , 2005, Ethnicity & disease.
[24] M. Cheitlin. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study , 2011 .
[25] P. Palatini. Heart rate as a cardiovascular risk factor , 1999 .
[26] Gregory Evans,et al. Laboratory, Reading Center, and Coordinating Center Data Management Methods in the Jackson Heart Study , 2004, The American journal of the medical sciences.
[27] M. Domanski,et al. Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction. , 2001, The New England journal of medicine.
[28] P. Simpson,et al. Statistical methods in cancer research , 2001, Journal of surgical oncology.
[29] K. Ellenbogen,et al. Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. , 1997, Journal of the American College of Cardiology.
[30] H. Taylor,et al. The Jackson Heart Study: an overview. , 2005, Ethnicity & disease.
[31] W. Rosamond,et al. Cardiovascular disease event classification in the Jackson Heart Study: methods and procedures. , 2005, Ethnicity & disease.
[32] Michael Böhm,et al. Resting heart rate: risk indicator and emerging risk factor in cardiovascular disease. , 2015, The American journal of medicine.
[33] D. Mikhailidis,et al. Elevated heart rate and atherosclerosis: an overview of the pathogenetic mechanisms. , 2008, International journal of cardiology.
[34] Sunil J Rao,et al. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis , 2003 .
[35] Deepak L. Bhatt,et al. Heart Rate at Hospital Discharge in Patients With Heart Failure Is Associated With Mortality and Rehospitalization , 2015, Journal of the American Heart Association.
[36] G. Fonarow,et al. Epidemiology and risk profile of heart failure , 2011, Nature Reviews Cardiology.